Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Clay Cather

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Proceedings (Baylor University. Medical Center)|October 4, 2005
Oral erosions and cutaneous bullaeTodd R Gleaves, Jennifer Clay Cather, Alan Menter
Dermatologic Clinics|October 17, 2002
Update on botulinum toxin for facial aestheticsJennifer Clay Cather, J Christian Cather, Alan Menter
The Journal of Clinical and Aesthetic Dermatology|April 1, 2017
Psoriasis and Psoriatic ArthritisJennifer Clay Cather, Melodie Young, Martin Jan Bergman
Expert Opinion on Biological Therapy|March 29, 2003
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumabJennifer Clay Cather, J Christian Cather, Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Diverse cutaneous manifestations associated with a single diseaseJennifer Clay Cather, Estil A Vance, M Alan Menter
Proceedings (Baylor University. Medical Center)|November 10, 2005
Psoriasiform lesions on trunk and palmsJennifer Clay Cather, John Christian Cather, M Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Meandering linear pruritic lesionJennifer Clay Cather, J Christian Cather, M Alan Menter
Advances in Dermatology|November 17, 2004
Update in the diagnosis of keratinocytic neoplasiaJennifer Clay Cather, J Christian Cather, Clay J Cockerell
Expert Opinion on Biological Therapy|June 9, 2021
Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasisJennifer Clay Cather, Chaney T Young, Melody S Young, et al.
Dermatology and Therapy|October 28, 2017
Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative StudyJennifer Clay Cather, Caitriona Ryan, Kim Meeuwis, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Proceedings (Baylor University. Medical Center)|October 4, 2005
Oral erosions and cutaneous bullaeTodd R Gleaves, Jennifer Clay Cather, Alan Menter
Dermatologic Clinics|October 17, 2002
Update on botulinum toxin for facial aestheticsJennifer Clay Cather, J Christian Cather, Alan Menter
The Journal of Clinical and Aesthetic Dermatology|April 1, 2017
Psoriasis and Psoriatic ArthritisJennifer Clay Cather, Melodie Young, Martin Jan Bergman
Expert Opinion on Biological Therapy|March 29, 2003
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumabJennifer Clay Cather, J Christian Cather, Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Diverse cutaneous manifestations associated with a single diseaseJennifer Clay Cather, Estil A Vance, M Alan Menter
Proceedings (Baylor University. Medical Center)|November 10, 2005
Psoriasiform lesions on trunk and palmsJennifer Clay Cather, John Christian Cather, M Alan Menter
Proceedings (Baylor University. Medical Center)|December 8, 2005
Meandering linear pruritic lesionJennifer Clay Cather, J Christian Cather, M Alan Menter
Advances in Dermatology|November 17, 2004
Update in the diagnosis of keratinocytic neoplasiaJennifer Clay Cather, J Christian Cather, Clay J Cockerell
Expert Opinion on Biological Therapy|June 9, 2021
Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasisJennifer Clay Cather, Chaney T Young, Melody S Young, et al.
Dermatology and Therapy|October 28, 2017
Patients' Perspectives on the Impact of Genital Psoriasis: A Qualitative StudyJennifer Clay Cather, Caitriona Ryan, Kim Meeuwis, et al.
Pageof 4